CD19 and systemic lupus erythematosus: In SLE, dysfunction of B-cell-intrinsic TLR9 prevents apoptosis of autoreactive B cells, so enhancing the TLR9 signal by upregulating CD19 may be a novel strategy for targeting TLR9 to treat SLE (13, 16, 98).